Clinical Trial Update: Prophylactic Trimethoprim/Sulfamethoxazole to Prevent Severe Infections in Patients With Lupus Erythematous [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating prophylactic trimethoprim/sulfamethoxazole to prevent severe infections in patients with systemic lupus erythematosus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• Trimethoprim-sulfamethoxazole (trimethoprim-sulfamethoxazole)

Snippet

Sponsor: Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran | Conditions: Lupus Erythematosus, Systemic | Phase 4 | Status: UNKNOWN